Lataa...
Cellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in Combination
MenBvac and MeNZB are safe and efficacious outer membrane vesicle (OMV) vaccines against serogroup B meningococcal disease. Antibody responses have previously been investigated in a clinical trial with these two OMV vaccines given separately (25 μg/dose) or in combination (12.5 and 12.5 μg/dose) in...
Tallennettuna:
| Julkaisussa: | Clin Vaccine Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4820518/ https://ncbi.nlm.nih.gov/pubmed/26865595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00666-15 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|